Literature DB >> 2466536

Substance P and serotonin act synergistically to activate a cation permeability in a neuronal cell line.

G Reiser1, B Hamprecht.   

Abstract

Both substance P and, to a lesser degree, serotonin activate cation permeability in neuroblastoma x glioma hybrid cells, as determined by measurement of [14C]guanidinium uptake. Serotonin potentiates the action of substance P by shifting the concentration-effect curve of substance P to the left. The EC50 value for the synergistic effect of serotonin was around 0.3 microM. Dopamine and noradrenaline displayed comparable activity, albeit only at 50 and 130 times higher concentrations, respectively. The order of potency of various substance P-analogues was not changed by serotonin, indicating that the specificity of the substance P site on the hybrid cells was not affected by serotonin. Various other neurotransmitters and peptides had no effect on the response of the hybrid cells to substance P. The serotonin receptor interacting with the substance P receptor may be classified as a 5-HT3-receptor since methysergide, cimetidine, and ketanserin were ineffective, but two inhibitors specific for 5-HT3-receptors, ICS 205-930 (3 alpha-tropanyl-1H-indole-3-carboxylic acid ester) and MDL 72222 (1 alpha H,3 alpha,5 alpha H-tropan-3-yl-3,5-dichlorobenzoate), blocked the effect of serotonin at nanomolar concentrations. However, the two serotonin antagonists might also be blocking the ion permeability, since at higher concentrations they fully inhibited the stimulation of guanidinium uptake by substance P or by substance P plus serotonin. The synergism between substance P and serotonin on the hybrid cells offers the opportunity to study the mechanism of interaction of neurotransmitter receptors on a permanent neuronal cell line.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2466536     DOI: 10.1016/0006-8993(89)91333-4

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  8 in total

1.  The antiemetic 5-HT3 receptor antagonist Palonosetron inhibits substance P-mediated responses in vitro and in vivo.

Authors:  Camilo Rojas; Ying Li; Jie Zhang; Marigo Stathis; Jesse Alt; Ajit G Thomas; Sergio Cantoreggi; Silvia Sebastiani; Claudio Pietra; Barbara S Slusher
Journal:  J Pharmacol Exp Ther       Date:  2010-08-19       Impact factor: 4.030

2.  Inhibition of 5-HT3 receptor function by imidazolines in mouse neuroblastoma cells: potential involvement of sigma 2 binding sites.

Authors:  G J Molderings; K Schmidt; H Bönisch; M Göthert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996 Aug-Sep       Impact factor: 3.000

3.  Increasing effect of ethanol on 5-HT3 receptor-mediated 14C-guanidinium influx in N1E-115 neuroblastoma cells.

Authors:  M Barann; K Ruppert; M Göthert; H Bönisch
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-08       Impact factor: 3.000

4.  Characterization of 5-HT3 receptors of N1E-115 neuroblastoma cells by use of the influx of the organic cation [14C]-guanidinium.

Authors:  H Bönisch; M Barann; J Graupner; M Göthert
Journal:  Br J Pharmacol       Date:  1993-02       Impact factor: 8.739

5.  Influence of sodium substitutes on 5-HT-mediated effects at mouse 5-HT3 receptors.

Authors:  M Barann; K Schmidt; M Göthert; B W Urban; H Bönisch
Journal:  Br J Pharmacol       Date:  2004-05-17       Impact factor: 8.739

6.  5-HT3 receptor antagonism by anpirtoline, a mixed 5-HT1 receptor agonist/5-HT3 receptor antagonist.

Authors:  M Göthert; M Hamon; M Barann; H Bönisch; H Gozlan; R Laguzzi; P Metzenauer; B Nickel; I Szelenyi
Journal:  Br J Pharmacol       Date:  1995-01       Impact factor: 8.739

Review 7.  Serotonin and beyond-a tribute to Manfred Göthert (1939-2019).

Authors:  H Bönisch; K B Fink; B Malinowska; G J Molderings; E Schlicker
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2021-05-15       Impact factor: 3.000

8.  Netupitant and palonosetron trigger NK1 receptor internalization in NG108-15 cells.

Authors:  Ajit G Thomas; Marigo Stathis; Camilo Rojas; Barbara S Slusher
Journal:  Exp Brain Res       Date:  2014-06-27       Impact factor: 1.972

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.